MSU co-authored study: 10 insights to reduce vaccine hesitancy on social media

Young Anna Argyris, associate professor in the Michigan State University Department of Media and Information, is part of an international team studying the detrimental effects of vaccine misinformation on social media and interventions that can increase vaccine uptake behaviors.

New Insights on Long COVID

David Winter, MD, at Baylor Scott & White Health, answers the most common patient questions and reacts to the latest medical research. What is long COVID, and how common is it? (SOT@ :14, TRT :32) Why do some people get…

Getting vaccines for flu, RSV, pneumonia and COVID.

David Winter, MD, at Baylor Scott & White Health, answers the most common patient questions and reacts to the latest medical research. With flu season approaching, who should get a flu shot and when? (SOT@ :14, TRT :24) RSV cases…

Dr. Marc Elieson discusses concerns about COVID-19 and kids going back to school

Marc Elieson, MD, at Baylor Scott & White Health, answers common patient questions and reacts to the latest medical research. The CDC says COVID cases will continue to increase this summer and when school resumes this fall. What is behind…

Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine: Implications for Infection Prevention and Transmission

The Icahn School of Medicine at Mount Sinai in New York, NY is pleased to announce that CastleVax, Inc. has completed enrollment and a preliminary analysis of a phase 1 trial of its licensed Newcastle disease virus (NDV)-based COVID-19 booster vaccine.

Rutgers Expert Available to Discuss Mixing and Matching of COVID-19 Vaccines, Booster Shots

Rutgers infectious disease expert Shobha Swaminathan is available to discuss the mixing and matching of COVID-19 vaccines and boosters as the Food and Drugs Administration authorized booster shots for both the Johnson & Johnson and Moderna vaccines. “There is mounting…

Rutgers Chancellor Available to Discuss COVID-19 Booster Shots, Why Frontline Workers Need Them

Brian L. Strom, chancellor at the Rutgers Biomedical and Health Sciences and executive vice president for Rutgers Health Affairs, is available to discuss the COVID-19 booster shot and why frontline workers need to get them. Strom agrees with the Centers…

Rutgers Global Health Expert Available to Discuss the Global Need for More COVID-19 Vaccines

Rutgers global health expert Richard Marlink, M.D., is available to discuss the importance of prioritizing vaccinations in low- to middle-income countries that need it the most, following President Biden’s pledge to donate an additional 500 million doses of the Pfizer-BioNTech COVID-19…

2VIDA! Tackles COVID Vaccine Hesitancy and Barriers in Latinx, Black Communities

UC San Diego is collaborating with San Ysidro Health on an NIH-funded outreach program to address COVID-19 vaccine hesitancy in Latinx and African American communities. The team runs pop-up vaccination sites across San Diego, and goes door-to-door to homes and local businesses to spread awareness.

Cancer Guidelines Organization Supports Mandatory COVID-19 Vaccination for Health Workers

National Comprehensive Cancer Network (NCCN) COVID-19 Vaccination Advisory Committee calls for healthcare workforce vaccine requirements to assure healthcare community is doing all it can to prevent exposure to COVID-19.

World-first COVID vaccine booster randomized clinical trial in transplant patients proves third shot is very effective

The study enrolled 120 transplant patients between May 25th and June 3rd. None of them had COVID previously and all of them had received two doses of the Moderna vaccine. Half of the participants received a third shot of the vaccine (at the 2-month mark after their second dose) and the other half received placebo.
The primary outcome was based on antibody level greater than 100 U/ml against the spike protein of the virus. In the placebo group – after three doses (where the third dose was placebo), the response rate was only 18% whereas in the Moderna three-dose group, the response rate was 55%.

World-first COVID vaccine booster randomized clinical trial in transplant patients proves third shot is very effective

The study enrolled 120 transplant patients between May 25th and June 3rd. None of them had COVID previously and all of them had received two doses of the Moderna vaccine. Half of the participants received a third shot of the vaccine (at the 2-month mark after their second dose) and the other half received placebo. The primary outcome was based on antibody level greater than 100 U/ml against the spike protein of the virus. In the placebo group – after three doses (where the third dose was placebo), the response rate was only 18% whereas in the Moderna three-dose group, the response rate was 55%.

Vaccine Hesitancy and Pregnancy: @UCSDHealth expert on why you should get the COVID-19 shot

With recent statewide vaccination mandates, members of the public may have questions or concerns about the safety and effectiveness of COVID-19 vaccination, especially in pregnant mothers. Cynthia Gyamfi-Bannerman, MD, professor and chair of Obstetrics, Gynecology and Reproductive Sciences at UC…

Response to COVID-19 Vaccines Varies Widely in Blood Cancer Patients

Patients with a type of blood cancer called multiple myeloma had a widely variable response to COVID-19 vaccines—in some cases, no detectable response—pointing to the need for antibody testing and precautions for these patients after vaccination, according to a study published in Cancer Cell in June.

Story Tips from Johns Hopkins Experts on COVID-19

How Can Scientists Predict a COVID-19 Outbreak? There’s an App for that; Johns Hopkins Medicine Collaborates with the City and Faith Organizations to Offer Guidance on Safely Reopening Houses of Worship; Johns Hopkins Hospital Patient ‘Grateful to Still Be Alive’ After Two-Month Hospitalization with COVID-19; “12 Things You Need To Know” Infographic…

Chula to Accelerate Research on “Rutin” — An Herbal Extract Against COVID-19

Chula researchers have found that “rutin” extract from orange peel can kill the COVID-19 virus. They are developing it into drugs while pointing out that drug research is still necessary along with vaccine research and suggesting that Thai people should adjust their views on herbs to create added value.

Who Has a Right to Ask if You’re Vaccinated?

COVID-19 vaccination has become a lightning rod for controversy over “vaccine passports” and claims of violations of medical privacy or individual rights. But as two experts explain, there’s a long history of efforts to protect the health of others by requiring individuals to provide proof of vaccination or of a past infection, or seek a medical or religious exception.

Rutgers Expert Addresses Questions on COVID-19 Vaccine Rollout and Variant Issues

Stanley H. Weiss, an epidemiologist in infectious and chronic diseases, and a professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health, talks about vaccine side effects, the hesitancy that still exists and why it is important to get vaccinated when it’s your turn.

Most young people eager for COVID-19 vaccine, poll shows

As older teens and young adults become eligible for COVID-19 vaccination across the country, and younger teens await their turn, new survey data suggest a strong readiness that has grown since fall. But just as with older generations, a shrinking but still sizable minority of people age 14 to 24 say they’re not willing to get vaccinated, or that their decision will depend on safety.

New Report: Vaccine Hesitancy and Acceptance Among Parents

A new report shows parents are more vaccine hesitant and resistant than non-parents (in terms of willingness to vaccinate themselves) across all socioeconomic and demographic groups compared. This pattern is largely driven by younger mothers, who are far more vaccine resistant than younger women who are not mothers. Older parents and fathers show little difference from their non-parent peers.

Endocrine Society joins ASBMR and other bone health organizations to provide guidance on COVID-19 vaccine and osteoporosis

As COVID-19 vaccines continue to be distributed, the world’s leading bone health research, clinical, and patient advocacy organizations ASBMR, Endocrine Society, AACE, ECTS, NOF, and IOF provide recommendations to assist clinicians in managing osteoporosis treatments for their patients who plan to get vaccinated. The full guidance document with supporting evidence is available at https://www.asbmr.org/about/statement-detail/joint-guidance-on-covid-19-vaccine-osteoporosis